How to find cancer clinical trials and check eligibility
Finding a cancer clinical trial starts with an accurate diagnosis and treatment history. Search using the cancer subtype, stage and relevant biomarker, then compare the study's entry criteria with your records. A registry listing helps you identify a study; the recruiting team confirms whether a site has an opening and whether you qualify. Ask about the treatment being tested, alternatives, visit demands and costs before arranging travel or changing your current care.
On this page
Build a useful search profile
Write a one-page summary with the pathology diagnosis, current stage, treatments already received and the reason each stopped. Add the latest scan date and relevant molecular results. Include current medicines and major health problems, because trial eligibility often extends beyond the cancer itself.
This helps a trial coordinator answer a specific question. 'Metastatic lung adenocarcinoma after a named treatment, with a particular mutation' is much more informative than 'lung cancer trial'. Keep the full reports alongside the summary so a preliminary match can be checked against the original details.
Sources and references: [1]
Search registries and the actual study site
ClinicalTrials.gov and NCI's trial search are useful starting points. Cancer-center research offices can also identify studies at their own institutions. Search by disease and treatment stage, then narrow by location and recruitment status.
Save the study identifier, title and contact details for each plausible option. Note when you checked it. A study may have several hospitals, with different recruitment situations at each. Ask the specific site whether screening is open before treating the registry entry as an available appointment.
Sources and references: [1]
Read inclusion and exclusion criteria together
A trial may require a particular tumor type, measurable disease, a biomarker or a defined number of earlier treatments. Organ function, infections, other medicines and overall fitness may affect eligibility. Exclusion criteria can be just as decisive as the headline diagnosis.
Make a list of what appears to match, what appears not to match and what is unclear. Let the study team resolve uncertain wording. Do not stop a medicine or postpone needed treatment to try to satisfy a criterion; discuss timing with your treating oncologist and the trial team.
Sources and references: [1]
Understand what participation involves
Ask what the study is trying to learn and how your treatment is assigned. If there is randomization, understand the possible groups before deciding. Request a comparison with the care available outside the trial, including symptom treatment and established cancer therapies.
Clarify which tests are routine care and which exist because of the research protocol. Extra biopsies, blood draws or hospital visits may affect your choice even when the treatment itself sounds appealing. Bring someone to the consent discussion if a second listener would help you remember the answers.
Check the schedule before the journey
Request a sample calendar covering screening, treatment and the first response assessment. Ask how often you must stay near the hospital and whether an unplanned admission would change your accommodation needs. For international travel, identify which follow-up visits must happen at the research site.
Separate the expected bills: research tests, standard medical care, medicines, hospital care and travel. Ask who handles a treatment-related complication and how those costs are managed. A written explanation is easier to use than a broad promise that a trial is 'free'.
Keep another treatment route open
Discuss how long it is clinically reasonable to wait for screening. Keep your current team informed while the study team checks the records. A possible trial should fit into a treatment plan with clear decisions about what happens if screening is delayed or unsuccessful.
You can also ask whether a new scan or pathology review is already needed for your normal care. Coordinating these requests may reduce unnecessary repeat work. The research site decides which outside tests it can accept and which need repeating under its protocol.
Exploring Shanghai options with EastMedGo
For a Shanghai inquiry, begin with the disease-specific team and a trial identifier if you have one. EastMedGo can help organize the administrative side of the inquiry, including the documents and questions needed for the hospital's research office. Enrollment and consent discussions belong with the trial clinicians.
Tell us the next decision you face and the date of any planned treatment. We can help clarify a consultation route and the practical arrangements if a Shanghai review is appropriate. Our specialist review information is a useful starting point when you also want established options reviewed.
Sources and references: [1]
Common questions
Can I join a trial before trying every standard treatment?
Some trials study the first treatment after diagnosis; others require previous therapy. Check the exact protocol early enough to discuss the choice before your treatment starts.
Sources and references: [1]
Does a matching mutation mean I am eligible?
It may satisfy one entry criterion. The trial team still checks the cancer type, earlier treatments, general health and all other requirements.
Sources and references: [1]
Can EastMedGo enroll me directly?
The research team handles eligibility assessment and informed consent. EastMedGo can help prepare and coordinate an inquiry so you can get a clear answer from that team.
Sources and references: [1]
Sources and references
Prepared with AI assistance by EastMedGo for patients comparing treatment and care options.